49 related articles for article (PubMed ID: 2695696)
21. Lack of influence of T-cell marker and importance of mediastinal mass on the prognosis of acute lymphocytic leukemias of childhood.
Hann HW; Lustbader ED; Evans AE; Toledano SR; Lillie PD; Jasko LB
J Natl Cancer Inst; 1981 Feb; 66(2):285-90. PubMed ID: 6969813
[TBL] [Abstract][Full Text] [Related]
22. [Chronic lymphatic leukemia. I. Clinico-biological features and survival analysis. Study of 187 patients].
Jarque I; Sanz G; Gomis F; Martínez G; de la Rubia J; López F; Sanz MA
Sangre (Barc); 1991 Aug; 36(4):277-84. PubMed ID: 1776106
[TBL] [Abstract][Full Text] [Related]
23. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
[TBL] [Abstract][Full Text] [Related]
24. [Epidemiologic, clinical and cytohematologic characteristics of adult acute lymphoblastic leukemia in Tunisia].
Elloumi M; Hafsia R; el Omri H; Souissi T; Hafsia A; Ennabli S; Ben Abdeladhim A
Tunis Med; 2002 Apr; 80(4):199-202. PubMed ID: 12416355
[TBL] [Abstract][Full Text] [Related]
25. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
27. [Effectiveness of allogeneic bone marrow transplantation in patients with acute leukemia in complete remission and in patients with chronic myeloid leukemia during the chronic phase].
Liubimova LS; Savchenko VG; Mendeleeva LP; Kliasova GA; Gribanova EO; Demidova IA; Gal'tseva IV; Kuz'mina LA; Momotiuk KS; Kuliev RG
Ter Arkh; 1999; 71(7):27-32. PubMed ID: 10481864
[TBL] [Abstract][Full Text] [Related]
28. [Possibilities of remission of acute lymphoblastic leukemia in adults: retrospective study of 51 patients subjected to a "total therapy" protocol in the period 1969-1983].
Sánchez Fayos J; Outeiriño J; Pacho E; Villalobos E; Calabuig T; Prieto E; Bosch JM; Sánchez Guilarte J; Rodríguez C
Rev Clin Esp; 1989 May; 184(9):464-9. PubMed ID: 2772323
[TBL] [Abstract][Full Text] [Related]
29. FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Cohen MH; Johnson JR; Justice R; Pazdur R
Oncologist; 2008 Jun; 13(6):709-14. PubMed ID: 18586926
[TBL] [Abstract][Full Text] [Related]
30. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
31. Interesting morphologic finding in T-cell acute lymphoblastic leukemia.
Paydas S
Diagn Cytopathol; 1999 Jul; 21(1):55-6. PubMed ID: 10405811
[TBL] [Abstract][Full Text] [Related]
32. [Acute T-cell lymphoproliferative syndromes. A study of 29 cases].
Ribera JM; Urbano-Ispizua A; Matutes E; Campo E; Grañena A; Vives-Corrons JL; Montserrat E; Rozman C
Med Clin (Barc); 1989 Oct; 93(13):481-5. PubMed ID: 2695696
[TBL] [Abstract][Full Text] [Related]
33. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA
Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652
[TBL] [Abstract][Full Text] [Related]
34. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
[TBL] [Abstract][Full Text] [Related]
35. Outcome of adult acute lymphoblastic leukemia: a single center experience.
Usman M; Burney I; Nasim A; Adil SN; Salam A; Siddiqui T; Khurshid M
J Pak Med Assoc; 2003 Sep; 53(9):384-8. PubMed ID: 14620310
[TBL] [Abstract][Full Text] [Related]
36. Is T-cell acute lymphoblastic leukemia still a high risk leukemia in children?
Cáp J; Foltinová A; Kaiserová E; Babusíková O; Jamárik M; Jasenková M
Neoplasma; 1998; 45(3):135-9. PubMed ID: 9717524
[TBL] [Abstract][Full Text] [Related]
37. [Primary myelofibrosis: description of a series of 53 patients].
Pereira A; Cervantes F; Montserrat E; Rozman C
Med Clin (Barc); 1989 Apr; 92(14):521-5. PubMed ID: 2666765
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
